tricular arrhythmia, left ventricular chamber size, ejection fraction or hemodynamics. Myocyte histologic findings were similar; however, myocarditis was identified in 29% of patients with peripartum cardiomyopathy and in only 9% of those with idiopathic dilated cardiomyopathy. In all patients with peripartum cardiomyopathy and myocarditis, the myocardial biopsy was performed within 1 week of onset of symptoms.
Seven (50%) of the patients with peripartum cardiomyopathy had dramatic improvement within 6 weeks of follow-up, and 6 (43%) died. Survivors had a higher ejection fraction (22.8 ± 11.7 versus 10.6 ± 1.5%, P < 0.05) and smaller left ventricular cavity size (5.8 ± 1.2 versus 6.9 ± 0.7 em, p < 0.05). Peripartum cardiomyopathy in a middle class population is hemodynamically indistinguishable from idiopathic dilated cardiomyopathy but is characterized by a high incidence of histologic myocarditis resulting in rapid, spontaneous improvement of congestive heart failure or progressive deterioration resulting in early death. (J Am Coil Cardiol 1986; 8:52-6) nutritional or dietary discrepancies (4) and more recently, myocarditis (5), have been implicated as possible causes of peripartum cardiomyopathy.
Some reports (2, 6) describe this syndrome in patients from lower socioeconomic strata who may not have enjoyed the benefit of high quality obstetric care. Peripartum cardiomyopathy has not been systematically analyzed in women receiving standard prenatal care nor have these patients been evaluated with current invasive and noninvasive cardiac techniques. The etiology of this form of dilated cardiomyopathy remains controversial; namely, is peripartum cardiomyopathy a specific disease of heart muscle or is the presentation of congestive heart failure in the peripartal period simply the initial presentation of latent idiopathic dilated cardiomyopathy? In an effort to clarify the precipitating factors in a middle class population and further characterize the features of this syndrome, we sequentially evaluated 14 patients with peripartum cardiomyopathy and compared their clinical, hemodynamic, histologic and prognostic characteristics with those of a nonselected group of patients with idiopathic dilated cardiomyopathy. ulation did so during the peripartal period and constitute the study group.
Statistical analysis. This was performed using the chisquare or the unpaired Student's t test. A probability value of less than 0.05 was considered significant. 
Results
Clinical characteristics. Table 1 is a summary of the cardiac history and obstetric characteristics of the 14 patients with peripartum cardiomyopathy . Risk factors for the development of coronary or myocardial disease, or both , were unusual in this patient population and, by definition, no patient had angiographic evidence of coronary artery disease . Only one individual was a cigarette smoker, two (14%) were diabetic and none of these patients admitted to regular alcohol use. Gestational hypertension was noted in four (29%) of these women . A viral prodrome before the onset of heart failure was noted in two patients (14%) .
Obstetric characteristics. These women had a broad spectrum of obstetric presentations. Eight (57%) developed heart failure concomitant with their first pregnancy and three had one or more previous pregnancies without cardiac symptoms. Three of these women delivered their infant prematurely. Two patients developed heart failure in conjunction with a twin gestation and six (43%) required cesarean section for delivery of their infant. The initial presentation of cardiac disease occurred before delivery in eight patients (57%) and in the first week postpartum in three (Fig. 1) . The high incidence of prematurity and cesarean section in this patient group may be a reflection of the development of heart failure before delivery because each of these women became symptomatic immediately before or concomitant with the onset of labor. The remaining three patients first developed symptoms of heart failure between the second and eighth week postpartum. None of these patients developed symptoms
Methods
Study patients. The patient population consisted of 14 consecutive women with peripartum cardiomyopathy referred to our center for diagnostic study . Peripartum cardiomyopathy was defined as left ventricular dilation and poor systolic function with normal wall thickness in the presence of symptoms of congestive heart failure. The onset had to commence during the third trimester of pregnancy or within 6 months after parturition. These women all had had high quality prenatal care and were without obvious nutritional deficiencies. Patients with known cardiac disease before pregnancy or evidence of valvular heart disease, pericardial disease or preexistent hypertension were excluded . Coronary angiography was performed in all patients over 30 years of age and in any patient with a suggestion of ischemic heart disease by history , electrocardiographic changes or coronary artery disease risk factors, that is, hyperlipidemia, family history of premature vascular disease, history of cigarette smoking or diabetes mellitus. Subsequent angiographic documentation of coronary artery disease excluded patients from analysis.
The baseline evaluation performed on all patients included a history and physical examination, right heart catheterization with a flow-directed catheter and thermodilution cardiac output recordings, right ventricular endomyocardial biopsy using the Stanford technique (7), gated blood pool scanning for the quantification of left and right ventricular ejection fractions as well as segmental wall motion abnormalities and M-mode and two-dimensional echocardiography. Gallium-67 imaging was attempted but breast uptake in the postpartum women obscured visual interpretation of myocardial uptake in both anterior and oblique views. Gated blood pool scanning and echocardiography were repeated every 3 months for the first year of follow-up. If active myocarditi s was detected on initial biopsy, the biopsy was repeated 6 weeks later. Patients were followed up closely but no attempt was made to standardize medical therapy. Baseline clinical , cardiac and obstetric variables were tabulated and compared with defined risk factors for development of peripartum cardiomyopathy as previously defined by Demakis and Rahimtoola (2) .
Control group. Baseline and follow-up characteristics of the patients with peripartum cardiomyopathy were compared with those of 55 consecutively evaluated patients with idiopathic dilated cardiomyopathy. An age-and sex-matched control group was not possible because the majority of young women presenting with dilated cardiomyopathy in our pop- than 30. Symptom duration was also significantly less in the study group. Complex ventricular arrhythmia detected by 24 hour ambulatory Holter monitoring was common in both groups, occurring in 60% of the study group and 76% of the patients with idiopathicdilated cardiomyopathy. Segmental wall motion abnormalities were present on radionuclide ventriculography in 8 (62%) of the patients with peripartum cardiomyopathy and in 32 (64%) of the patients with idiopathic dilated cardiomyopathy. Mean radionuclide left ventricularejection fraction was similar in both groups. Echocardiographic left ventricular enlargement was present in both groups to an equal degree. The pulmonary artery systolic pressure was similar in each group, as was the pulmonary artery wedge pressure. A cardiac index of less than 2.2 liters/min per m 2 occurred with equal frequency in each group (36% in both the study and comparison groups).
Findings on endomyocardial biopsy. Histologic abnormalities, including myocyte hypertrophy, nuclear hyperchromaticity and interstitial fibrosis, were qualitatively . Comparison with control cardiomyopathy group. In an effort to ascertain whether peripartum cardiomyopathy represents a unique form of heart disease or the initial presentation of latent idiopathic dilated cardiomyopathy, clinical and hemodynamic comparisons were made between these patients and 55 consecutive patients with idiopathic dilated cardiomyopathy ( Table 2 ). The group with peripartum cardiomyopathy was younger;6 (43%)of the 14patients were less than 30 years of age, whereas only 5 (9%) of the 55 patients with idiopathicdilated cardiomyopathy were less In each of the patients with peripartum cardiomyopathy and myocarditis, the endomyocardial biopsy had been performed within 1 week after the onset of symptoms, which represented a 67% incidence of myocarditis (four positive biopsies of six performed within 1 week of onset). Treatment and follow-up. The study group was treated with standard medical therapy for congestive heart failure, restriction of activity and anticoagulant agents. Of the four patients with biopsy-proven myocarditis, only one received immunosuppressive therapy and she had a stable clinical course without deterioration of clinical or hemodynamic findings. The mean follow-up period was 12.1 ± 11.5 months for the patients with peripartum cardiomyopathy. Six (43%) of the patients with peripartum cardiomyopathy died during the follow-up period, whereas seven (50%) had dramatic improvement with resolution of clinical symptoms, discontinuation of cardiotonic medication, normalization of the left ventricular end-diastolic dimension on echocardiography and dramatic improvement of left ventricular ejection fraction (>20%); one patient remained clinically stable. Of the four patients with active myocarditis on biopsy, two died, one suddenly of a ventricular arrhythmia; the remaining two survived, one in improved condition and one whose condition stabilized. 
Discussion
Clinical characteristics. This study describes the clinical and hemodynamic presentation of 14 consecutively encountered women with peripartum cardiomyopathy. They received compulsory prenatal care and had no obvious evidence of dietary or nutritional deficiencies. Their obstetric characteristics show some distinct differences from those previously described in patients with peripartum cardiomyopathy (2) . Although a modest majority of these patients were over 30 years of age at the time of presentation, the incidence of delivery after age 30 is similar to that of our contemporary obstetric population without peripartum cardiomyopathy. Demakis and Rahimtoola (2) reported a higher incidence in women after their third or subsequent pregnancy than after their first or second. This was not true in our series; 57% of our patients were primiparous. In the vast majority of women from the same metropolitan area (Chicago) in the 1960s presenting with heart failure, the failure developed 1 to 3 months after delivery (2), whereas it occurred in fewer than 10% before delivery. This is another distinct difference from our patients in that 8 (57%) developed congestive heart failure before delivery. Fetal outcome in our group of patients was excellent. Although three infants were delivered prematurely, their growth and development was normal. The 43% incidence of cesarean section in our patient group reflects the current approach to obstetric care in the patients with congestive heart failure.
Comparison with idiopathic dilated cardiomyopathy. The critical question as to whether peripartum cardiomyopathy represents a unique clinical entity or is merely the first manifestation of latent heart disease that emerges during the increased metabolic and hemodynamic demands of pregnancy needs to be resolved. We attempted to identify the unique aspects of this syndrome by comparing the study patients with 55 patients with idiopathic dilated cardiomyopathy. We realize that, ideally, age-and sex-matched control subjects would be necessary to ascertain similarities and differences; however, the development of a cardiomyopathic state in young women other than during the peripartal period is unusual and makes strictly matched control subjects impossible. Hemodynamic and clinical comparisons could not distinguish patients with peripartum cardiomyopathy as a unique subgroup within the larger group of patients with dilated cardiomyopathy.
Common clinical and hemodynamic characteristics were not surprising, and we sought to further compare histologic features. Myocyte hypertrophy, interstitial fibrosis and nuclear hyperchromaticity were common in both the comparison and study groups. Deposition of proteinaceous material, a unique finding previously reported by Sakakibara et al. (8) , was not found. The most intriguing difference, however, was noted in the incidence of myocarditis. Only 9% of patients with idiopathic dilated cardiomyopathy had myo-carditis on biopsy. This rate is similar to our previously reported incidence of myocarditis (9) . The incidence of biopsy-proven myocarditis in our patients with peripartum cardiomyopathy was substantially higher (29%). Most interestingly, myocarditis was identified only in individuals who underwent biopsy within 1 week of the onset of symptoms. This suggests that myocarditis may play an important role early in the development of peripartum cardiomyopathy and may be missed if biopsy is performed later. A high incidence of myocarditis was previously reported by Melvin et al. (5) . They identified myocarditis in three consecutive patients presenting with peripartum cardiomyopathy. Their patients were treated with immunosuppressive therapy and showed significant improvement. Immunosuppressive therapy was used in only one of our patients with myocarditis. She had a stable clinical course after therapy. Two patients died with active myocarditis; the other had dramatic improvement without immunosuppressive therapy.
Outcome of peripartum cardiomyopathy. The prognosis of peripartum cardiomyopathy is distinctly different from that of other forms of dilated cardiomyopathy. Of the 14 patients, 7 died during the follow-up period. All seven patients whose condition improved had dramatic improvement within 6 weeks of presentation. These results are similar to those of Demakis and Rahimtoola (2). The small number of patients precluded most statistical evaluations between survivors and nonsurvivors except for ejection fraction and left ventricular end-diastolic dimension; nonsurvivors had a lower mean ejection fraction and a higher mean left ventricular end-diastolic dimension.
Etiologic factors: role of viral myocarditis. If peripartum cardiomyopathy represents a unique cardiomyopathy, etiologic factors that would characterize the unique heart muscle abnormalities should be identifiable. Previously, dietary and nutritional factors were thought to contribute to the development of congestive heart failure. This seems less likely in a middle class urban population with good prenatal care. We would propose a different etiologic possibility in view of the documentation of a shift of onset from 6 weeks postpartum to shortly before delivery and an increased incidence of myocarditis. Pregnancy may predispose women to a more severe form of viral myocarditis when they are infected by a cardiotropic virus. Pregnant mice have enhanced susceptibility to viral myocarditis when they are infected with either Coxsackie or encephalomyocarditis viruses (10, 11) . Immunologic studies in women have demonstrated enhanced suppressor cell activity during pregnancy (12) , which could augment susceptibility to viral infections (13, 14) . Immunologic function begins to normalize soon after delivery and this may enhance viral clearance and account for the rapid lessening of symptoms and hemodynamic abnormalities. The documented immunologic abnormality of pregnancy serves as a basis for an attractive hypothesis that peripartum cardiomyopathy is the result of increased susceptibility of pregnant women to viral myocarditis.
Conclusion. Although this study has not defined peripartum cardiomyopathy as an entity distinct from idiopathic dilated cardiomyopathy, the presence of congestive heart failure during the peripartal period is associated with a high incidence of myocarditis and a prognosis characterized by either dramatic resolution of signs and symptoms over a short period of time or continued deterioration resulting in death. The previously described risk factors for the development of this syndrome may no longer be valid. It is therefore suggested that after early institution of medical management, if further clinical deterioration is evident, early cardiac transplantation in peripartum cardiomyopathy be considered.
